- Stocks
- Healthcare
- NASDAQ: NXGN

Price (delayed)

$15.95

Market cap

$1.07B

P/E Ratio

79.75

Dividend/share

N/A

EPS

$0.2

Enterprise value

$1.03B

Nextgen Healthcare's EPS has surged by 150% YoY and by 43% QoQ

NXGN's net income has soared by 143% YoY and by 39% QoQ

The quick ratio has plunged by 54% YoY but it has grown by 8% from the previous quarter

What are the main financial stats of NXGN

Market
Valuations
Earnings

Shares outstanding

67.27M

Market cap

$1.07B

Enterprise value

$1.03B

Price to earnings (P/E)

79.75

Price to book (P/B)

2.44

Price to sales (P/S)

1.87

EV/EBIT

70.56

EV/EBITDA

15.03

EV/Sales

1.8

Revenue

$572.03M

EBIT

$14.62M

EBITDA

$68.63M

Free cash flow

$52.51M

Per share
Balance sheet
Liquidity

EPS

$0.2

Free cash flow per share

$0.78

Book value per share

$6.54

Revenue per share

$8.52

TBVPS

$4.21

Total assets

$624.56M

Total liabilities

$186M

Debt

$28.43M

Equity

$438.57M

Working capital

$39.13M

Debt to equity

0.06

Current ratio

1.25

Quick ratio

0.93

Net debt/EBITDA

-0.61

Margins
Efficiency
Dividend

EBITDA margin

12%

Gross margin

50.7%

Net margin

2.3%

Operating margin

2.6%

Return on assets

2%

Return on equity

3.1%

Return on invested capital

12.5%

Return on capital employed

3.1%

Return on sales

2.6%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Nextgen Healthcare stock price performed over time

Intraday

0.38%

1 week

-2.09%

1 month

-3.45%

1 year

11.85%

YTD

-12.55%

QTD

-3.86%

How have Nextgen Healthcare's revenue and profit performed over time

Revenue

$572.03M

Gross profit

$290.23M

Operating income

$14.67M

Net income

$13.19M

Gross margin

50.7%

Net margin

2.3%

NXGN's operating income has surged by 162% year-on-year and by 14% since the previous quarter

The operating margin has soared by 160% YoY and by 13% QoQ

NXGN's net income has soared by 143% YoY and by 39% QoQ

The net margin has soared by 130% YoY and by 35% from the previous quarter

What is Nextgen Healthcare's growth rate over time

What is Nextgen Healthcare stock price valuation

P/E

79.75

P/B

2.44

P/S

1.87

EV/EBIT

70.56

EV/EBITDA

15.03

EV/Sales

1.8

Nextgen Healthcare's EPS has surged by 150% YoY and by 43% QoQ

The price to earnings (P/E) is 49% less than the 5-year quarterly average of 155.2 and 36% less than the last 4 quarters average of 125.0

The P/B is 13% below the 5-year quarterly average of 2.8 and 7% below the last 4 quarters average of 2.6

NXGN's equity is up by 9% year-on-year

The stock's price to sales (P/S) is 7% less than its last 4 quarters average of 2.0

The revenue has increased by 6% YoY and by 2.7% from the previous quarter

How efficient is Nextgen Healthcare business performance

NXGN's ROA has soared by 150% YoY and by 43% from the previous quarter

Nextgen Healthcare's ROE has soared by 121% YoY and by 35% from the previous quarter

Nextgen Healthcare's return on sales has surged by 100% YoY and by 13% QoQ

The return on invested capital has surged by 67% since the previous quarter

What is NXGN's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for NXGN.

How did Nextgen Healthcare financials performed over time

The quick ratio has plunged by 54% YoY but it has grown by 8% from the previous quarter

The total liabilities has decreased by 49% YoY and by 13% QoQ

The debt is 94% less than the equity

The debt to equity has plunged by 89% YoY and by 14% from the previous quarter

The debt has plunged by 87% YoY and by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.